Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ariad Pharm Inc (ARIA)

Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,663,416
  • Shares Outstanding, K 194,390
  • Annual Sales, $ 118,800 K
  • Annual Income, $ -231,160 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 2.16
  • Price/Sales 25.04
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.17
  • Most Recent Earnings $-0.12 on 11/07/16
  • Next Earnings Date 02/28/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/16
See More
  • Average Estimate -0.18
  • Number of Estimates 4
  • High Estimate -0.18
  • Low Estimate -0.19
  • Prior Year -0.32
  • Growth Rate Est. (year over year) +43.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.63 +1.52%
on 01/27/17
23.99 unch
on 02/15/17
+0.30 (+1.27%)
since 01/13/17
3-Month
11.69 +105.22%
on 12/22/16
23.99 unch
on 02/15/17
+10.79 (+81.74%)
since 11/15/16
52-Week
4.67 +413.70%
on 02/24/16
23.99 unch
on 02/15/17
+19.27 (+408.26%)
since 02/12/16

Business Summary

Ariad Pharmaceuticals is engaged in the discovery and development of novel pharmaceuticals based on intracellular signaling technology. The Company has established highly integrated capabilities in functional genomics, molecular cell biology, structure based drug design, combinatorial chemistry and...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 24.02
1st Resistance Point 24.01
Last Price 23.99
1st Support Level 23.96
2nd Support Level 23.92
3rd Support Level N/A

See More

52-Week High 23.99
Last Price 23.99
Fibonacci 61.8% 16.61
Fibonacci 50% 14.33
Fibonacci 38.2% 12.05
52-Week Low 4.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar